Literature DB >> 17145155

Breast imaging and reporting data system (BIRADS): magnetic resonance imaging.

Anne A Tardivon1, Alexandra Athanasiou, Fabienne Thibault, Carl El Khoury.   

Abstract

This article reviews the technical aspects and interpretation criteria in breast MR imaging based on the first edition of breast imaging and reporting data system (BIRADS) published by the American College of Radiology (ACR) in 2003. In a second article, practical cases will be proposed for training the readers. The major aims of using this lexicon are: first to use a logical and standardized description of MR lesions, secondly to obtain a structured MR report with a clear final impression (BIRADS assessment categories), and thirdly to help comparison between different clinical studies based on similar breast MRI terminology.

Entities:  

Mesh：

Year:  2006        PMID： 17145155     DOI： 10.1016/j.ejrad.2006.08.036

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN： 0720-048X            Impact factor:   3.528


  12 in total

1.  The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.

Authors:  M D Dorrius; R M Pijnappel; M C van der Weide Jansen; L Jansen; P Kappert; M Oudkerk; P E Sijens
Journal:  Eur Radiol       Date:  2011-11-11       Impact factor: 5.315

2.  Magnetic resonance imaging of primary breast lymphoma.

Authors:  S Rizzo; L Preda; G Villa; S Brambilla; G Pruneri; A Alietti; E Cassano; G Martinelli; M Bellomi
Journal:  Radiol Med       Date:  2009-06-26       Impact factor: 3.469

3.  Characterizing and eliminating errors in enhancement and subtraction artifacts in dynamic contrast-enhanced breast MRI: Chemical shift artifact of the third kind.

Authors:  Jamal J Derakhshan; Elizabeth S McDonald; Evan S Siegelman; Mitchell D Schnall; Felix W Wehrli
Journal:  Magn Reson Med       Date:  2017-08-24       Impact factor: 4.668

4.  Clinical outcome of magnetic resonance imaging-detected additional lesions in breast cancer patients.

Authors:  Gi-Won Ha; Mi Suk Yi; Byoung Kil Lee; Hyun Jo Youn; Sung Hoo Jung
Journal:  J Breast Cancer       Date:  2011-09-29       Impact factor: 3.588

5.  High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Authors:  K Pinker-Domenig; W Bogner; S Gruber; H Bickel; S Duffy; M Schernthaner; P Dubsky; U Pluschnig; M Rudas; S Trattnig; T H Helbich
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

6.  Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.

Authors:  T A Heusner; S Hahn; C Jonkmanns; S Kuemmel; F Otterbach; M E Hamami; A R Stahl; A Bockisch; M Forsting; G Antoch
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

7.  The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases.

Authors:  Matthias Dietzel; Pascal A T Baltzer; Tibor Vag; Aimee Herzog; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

8.  Adjacent vessel sign and breast imaging reporting and data system are valuable for diagnosis of benign and malignant breast lesions.

Authors:  Suhong Zhao; Ru Tan; Jianjun Xiu; Xianshun Yuan; Qingwei Liu
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-29       Impact factor: 1.632

9.  MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation.

Authors:  Brittany Z Dashevsky; Jung Hun Oh; Aditya P Apte; Blanca Bernard-Davila; Elizabeth A Morris; Joseph O Deasy; Elizabeth J Sutton
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

10.  Accuracy of the Fischer scoring system and the Breast Imaging Reporting and Data System in identification of malignant breast lesions.

Authors:  Hanaa Al-Khawari; Reji Athyal; Agnes Kovacs; Mervat Al-Saleh; John Patrick Madda
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.